OF
Therapeutic Areas
PrognomiQ Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Multi-Omics Early Detection Platform | Multi-Cancer Early Detection (MCED) | Discovery/Pre-Clinical |
| Lung Cancer Detection Program | Early Detection of Lung Cancer | Phase 1 |
Leadership Team at PrognomiQ
PM
Philip Ma, PhD
Chief Executive Officer, Founder, Board Member
DS
David Siewers
Chief Financial Officer
BK
Brian Koh, MD
Chief Medical Officer
BW
Bruce Wilcox, PhD
Chief Technology Officer
KD
Katherine Dalao
VP, Quality Assurance and Clinical Lab Affairs
ML
Manway Liu, PhD
VP, Data Sciences
MR
Madhuvanthi Ramaih, PhD
VP, Product Management and Project Management Office
TB
Tomer Berkovitz, PhD
Board of Directors
RG
Raj Garg, MD, JD
Board of Directors
MM
Mark McClellan, MD, PhD
Board of Directors